Document Detail


Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status.
MedLine Citation:
PMID:  25211166     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Dysregulation of the chemokine receptor CXCR4 is relevant in melanoma progression, and the CXCR4/CXCL12 axis has been shown to activate cell cycle progression and malignant cell migration through stimulation of the mitogen-activated protein kinase pathway. Studies ascertaining the potential utility of CXCR4 mRNA as a prognosticator in melanoma have focused mainly on metastatic melanoma with conflicting results. In the light of this, we sought to explore the potential relationship between CXCR4 mRNA expression with established histopathologic prognosticators and BRAF status in melanoma. Archived consecutive samples (n=107) of primary cutaneous melanoma were retrieved and assessed for the following: CXCR4 mRNA (semiquantitative RT-PCR) and BRAF exon 15 status (DNA Sanger sequencing). Statistical analyses included correlation between CXCR4 mRNA levels and established histopathologic prognosticators as well as the BRAF status using univariate and multiple linear methods. Multivariable analyses revealed a significant correlation between elevated CXCR4 mRNA (low ΔCt value) and the presence of BRAF mutation (P=0.02). Absence of a brisk host response was associated with elevated CXCR4 mRNA expression (P=0.04). CXCR4 mRNA was significantly lower in AJCC stage 2 compared with stage 1 after controlling for significant clinical prognosticators (P=0.02). The association between elevated CXCR4 mRNA and absence of a brisk host response suggests that CXCR4 may be involved in regulation of the host immune response in melanoma and is a molecule of potential utility as a biomarker for recruiting melanoma patients for immunotherapy. Higher CXCR4 mRNA in patients with a BRAF mutation suggests its utility as a putative therapeutic target.
Authors:
Brendon Mitchell; Dominick Leone; John K Feller; Philip Bondzie; Shi Yang; Hee-Young Park; Meera Mahalingam
Related Documents :
1903196 - Transfected mouse c-jun can inhibit transformation of primary rat embryo fibroblasts.
14720506 - The tight junction protein zo-2 associates with jun, fos and c/ebp transcription factor...
11792626 - Jnk1 and ap-1 regulate pma-inducible squamous differentiation marker expression in clar...
16966326 - Induction of transcriptionally active jun proteins regulates drug-induced senescence.
25172656 - Mirna-dependent cross-talk between vegf and ang-2 in hypoxia-induced microvascular dysf...
24838976 - The ring-finger e3 ubiquitin ligase cop1 suppressor1 negatively regulates cop1 abundanc...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-10
Journal Detail:
Title:  Melanoma research     Volume:  -     ISSN:  1473-5636     ISO Abbreviation:  Melanoma Res.     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9109623     Medline TA:  Melanoma Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  c-MET expression in primary and liver metastases in uveal melanoma.
Next Document:  SmI2-H2O-mediated 5-exo/6-exo lactone radical cyclisation cascades.